At fast-growing Allied Digestive Health, with 194 gastrointestinal (GI) physicians, 75 nurse practitioners and locations throughout New Jersey and New York, COO Sap Sinha is excited about the future. “Private equity in general is looking at GI very specifically, and there are multiple reasons for it,” Sap says in this conversation with McGuireWoods partner and host Geoff Cockrell.
One reason is that colon cancer is the second-largest cause of cancer death in the United States. Sap describes the current landscape, in which Allied focuses on clinical quality and partnerships with large institutions. It also invests in frontier treatments, such as the use of genetic testing to detect colon cancer and weight management tools to control liver disease among obese patients.